4
Changes in Ownership
Equillium, Inc. Filed Acc 0001209191-21-060004
Chief Scientific Officer sold 8,092 shares at an average $7.01 ($56,706)
- Chief Scientific Officer acquired 8,092 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Connelly Stephen Chief Scientific Officer | 2021-10-06 | Option exercise | +5,625 | $4.75 | $26,719 | 998,625 | D |
| Connelly Stephen Chief Scientific Officer | 2021-10-06 | Sale | −5,625 | $7.01 | $39,418 | 993,000 | D |
| Connelly Stephen Chief Scientific Officer | 2021-10-06 | Option exercise | +2,467 | $2.80 | $6,908 | 995,467 | D |
| Connelly Stephen Chief Scientific Officer | 2021-10-06 | Sale | −2,467 | $7.01 | $17,288 | 993,000 | D |
| Derivatives | |||||||
| Connelly Stephen Chief Scientific Officer | 2021-10-06 | Option exercise · Employee Stock Option (right to buy) | −5,625 | 0 | D | ||
| Connelly Stephen Chief Scientific Officer | 2021-10-06 | Option exercise · Employee Stock Option (right to buy) | −2,467 | 0 | D | ||
| Open-market sales · 8,092 sh · avg $7.01 · $56,706 | |||||||
Loading xslF345X03/doc4.xml…